Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | -0.53% | +33.33% | -5.53% |
05-14 | Cantor Fitzgerald Adjusts Price Target on Exagen to $7 From $5, Maintains Overweight Rating | MT |
05-13 | Exagen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.53% | 32.8M | |
+19.28% | 84.52B | |
-26.95% | 72.21B | |
+4.65% | 27.74B | |
-7.35% | 17.97B | |
-0.46% | 17.46B | |
+4.69% | 15.82B | |
+8.14% | 13.55B | |
+6.59% | 13.31B | |
+70.00% | 12.5B |
- Stock Market
- Equities
- XGN Stock
- News Exagen Inc.
- Earnings Flash (XGN) EXAGEN Reports Q3 Revenue $12.3M, vs. Street Est of $12.1M